Business Context and Reporting Period
Company: Psyence Biomedical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2026
Date Filed: August 6, 2026
Principal Executive Office: Toronto, Ontario, Canada
This filing serves to furnish an investor presentation dated August 2026, which was made available to investors on August 3, 2026, and posted on the company's website.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is a procedural filing to incorporate an investor presentation by reference and does not contain a standalone financial statement or tabular data within the provided text.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document solely references the distribution of an investor presentation.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the release of an investor presentation (Exhibit 99.1) but does not summarize the content, guidance, or outlook contained within that presentation.
Risks and Contingencies: No specific risks or contingencies are disclosed in the text of this filing.
Key Facts for Investor Verification
- Verify the content of the Investor Presentation (Exhibit 99.1) for actual financial data, strategic updates, and forward-looking statements, as this filing only references the document.
- Confirm the filing date of August 6, 2026, and the presentation date of August 2026.
- Note that the registrant files annual reports under Form 20-F.